Picture of Medipharm Labs logo

LABS — Medipharm Labs News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: MediPharm Labs Reports Fourth Quarter And Full Year 2022 Results

March 31 (Reuters) - Medipharm Labs Corp  LABS.TO :
    * MEDIPHARM LABS REPORTS FOURTH QUARTER AND FULL YEAR 2022
RESULTS
    * MEDIPHARM LABS CORP - IMPLEMENTED RESTRUCTURING PLAN THAT
MANAGEMENT EXPECTS COULD REDUCE CANADIAN NON-MANUFACTURING
HEADCOUNT BY APPROXIMATELY 30%
    * MEDIPHARM LABS CORP - EXPECTS RESTRUCTURING PLAN TO
POTENTIALLY
REDUCING ANNUALIZED EXPENSES BY APPROXIMATELY $3M
    * MEDIPHARM LABS CORP - AIMS TO REACH POSITIVE EBITDA AND
CASH
FLOW IN FIRST HALF OF 2024
    * MEDIPHARM LABS CORP - AT END OF Q4 2022, CO HAD $24
MILLION IN
CASH ON ITS BALANCE SHEET

Source text for Eikon:  ID:nCNW4cMRka 
Further company coverage:  LABS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Medipharm Labs

See all news